Druck Icon

Eckert & Ziegler resolves capital increase

(Ad hoc press release)

Berlin, 12th January 2009. - The Board of Directors at Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) has resolved today with the consent of the Supervisory Board to implement a capital increase for cash with a partial utilisation of the approved capital in volumes of up to 628,633 new shares. With the expected funds inflow parts of the purchase price and the net current assets are to be financed in connection with the acquisition of a competitor. As announced on 22 December 2008 Eckert & Ziegler acquired the buyer's option.

The shareholders of the company will be granted a purchase right. Trading the purchase rights via the stock exchange is not possible. The new shares will not be permitted to be traded on the regulated market until further notice so that no stock market trading will take place. The company intends to effect the listing of the new shares at a later date. Linked to this is the prior establishment and approval of a securities prospectus according to the regulations of the Securities Prospectus Act. BankM, representation of biw Bank für Investments und Wertpapiere AG, has been commissioned with monitoring the capital increase.

Supplementary text: An interview with the Chairman of the Board, Dr. Andreas Eckert, on the topic of capital increase will be published at www.ezag.de. To read the interview click here.

The Board of Directors